Newsmeme!
Discover News you didn't know existed
GlaxoSmithKline (NYSE: GSK) announced that the United States Food and Drug Administration (FDA) granted accelerated approval for PROMACTA(R) (eltrombopag) for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.
Thousand Oaks, California, November 21 (ots/PRNewswire) - - First and Only Approved Platelet Producer Represents New Treatment Approach for Serious Chronic ...
Thousand Oaks, California, November 21 (ots/PRNewswire) - - First and Only Approved Platelet Producer Represents New Treatment Approach for Serious Chronic Autoimmune Disorder Amgen (Nasdaq: AMGN) today announced that the ...
Amgen today announced that the European Committee for Medicinal Products for Human Use has issued a positive opinion recommending marketing authorisation for Nplate in the European Union .
The Jefferson Health System Inc. , which parted with Albert Einstein Healthcare Network earlier this year, is now splitting with Frankford Health Care System Inc.
NEW YORK, Nov 20 (Reuters) - GlaxoSmithKline Plc said on Thursday its new platelet-boosting drug, Promacta, had been granted accelerated approval by the U.S. Food and Drug Administration. Promacta, also known by the chemical name eltrombopag, is approved for the treatment of patients with chronic immune thrombocytopenic purpura (ITP) who have had an insufficient response to corticosteroids, ...
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that the U.S. Food and Drug ...
SAN DIEGO----Ligand Pharmaceuticals Incorporated announced today that the U.S. Food and Drug Administration has granted accelerated approval of GlaxoSmithKline’s PROMACTA® for the treatment of thrombocytopenia in patients with chronic immune thrombocytopenic purpura who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.
Colostrum intake is critical for the newborn calf, says Greg Lardy, a North Dakota State University Extension Service beef cattle specialist. “At birth, a calf's immune system is not fully developed,” he says.
Researchers have just discovered a key mechanism that maintains the essential balance between bacteria living in our intestine and the immune system controlling them. Their research, published in the journal Nature, paves the way for new forms of treatment for infectious diseases of the intestine, such as dysentery, or chronic inflammatory diseases, such as Crohn's disease.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |